Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development.
Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, Ouattara A, Traoré K, Niangaly A, Djimdé AA, Doumbo OK, Plowe CV.
Takala SL, et al. Among authors: batchelor ah.
Sci Transl Med. 2009 Oct 14;1(2):2ra5. doi: 10.1126/scitranslmed.3000257.
Sci Transl Med. 2009.
PMID: 20165550
Free PMC article.